Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer’’s disease

Author： Barcia E.   Salama A.   Fernáández-Carballido A.   Negro S.  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.19, Iss.8, 2011-09, pp. : 637-646

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clioquinol: novel agent for Alzheimer's disease?

By  

Inpharma, Vol. 1, Iss. 1353, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres

By Yang Yang   Gao Yongliang   Mei Xingguo  

Pharmaceutical Development and Technology, Vol. 18, Iss. 5, 2013-10 ,pp. : 1169-1174

Informa Healthcare

Access to resources Recommend Favorite

Identification and Characterization of the Human Cytosolic Sulfotransferases Mediating the Sulfation of Clioquinol and Iodoquinol

By  

Drug Metabolism Letters, Vol. 10, Iss. 3, 2016-09 ,pp. : 200-205

Bentham Science Publishers

Access to resources Recommend Favorite

Human β-secretase and Alzheimer’s disease

By Citron Martin  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 341-348

Informa Healthcare

Access to resources Recommend Favorite

Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5076-5084

Bentham Science Publishers

Access to resources Recommend Favorite